Methylation array analysis and quantitative methylation-specific PCR (qMSP) confirmed an increase in the methylation level exceeding 50% at five CpG sites within SRCIN1 in tissue samples from breast cancer patients in both the TCGA and Taiwanese cohorts. This evidence concerns the gene SRCIN1 and breast carcinoma.